For patients with colorectal cancer, the long-term use of statins is associated with better clinical outcomes

Ali A. Siddiqui, Hector Nazario, Amar Mahgoub, Mahir Patel, Daisha Cipher, Stuart J. Spechler

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Abstract

Statins have been found to suppress tumor cell growth and to limit the ability of tumor cells to metastasize in studies involving cell lines and animals. To explore how the long-term use of statins influences the presentation and survival of patients with colorectal cancer (CRC), we conducted a retrospective case-control study of male patients with a new diagnosis of CRC who we categorized as: (1) Statin Users who used statins continuously ≥3 years prior to the diagnosis of CRC and (2) Statin Non-Users who did not use statins. Clinical factors were analyzed by simple Chi-square and multivariate regression analysis to identify independent predictors for advanced CRC. We identified 1,309 male patients with a new diagnosis of CRC (mean age 69 ± 1.1 (SE) years; 326 Statin Users, 983 Statin Non-Users). Compared to Statin Non-Users, Statin Users had a less advanced tumor stage (2.2 vs. 2.6; P < 0.01), a lower prevalence of metastases (OR = 0.7 [0.4-0.9, 95% CI]; P < 0.01), and a higher frequency of right-sided tumors (OR = 1.6 [1.3-2.1], 95%CI]; P < 0.01). Overall 5-year survival for Statin Users was 37% compared to 33% in Statin Non-Users (OR = 0.7 [0.6-0.9], 95%CI]; P = 0.03). In patients who present to the hospital with CRC, the long-term use of statins is associated with a less advanced tumor stage, a higher prevalence of right-sided tumors, a lower frequency of distant metastases, and a better survival rate.

Original languageEnglish (US)
Pages (from-to)1307-1311
Number of pages5
JournalDigestive Diseases and Sciences
Volume54
Issue number6
DOIs
StatePublished - Jun 1 2009

Keywords

  • 3-Hydroxy-3-methyl glutaryl coenzyme A inhibitors
  • Colorectal cancer
  • Metastasis

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Fingerprint

Dive into the research topics of 'For patients with colorectal cancer, the long-term use of statins is associated with better clinical outcomes'. Together they form a unique fingerprint.

Cite this